Psychometric Assessment of the Chinese Version of the Indian Vision Functioning Questionnaire Based on the Method of Successive Dichotomizations.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Association for Research in Vision and Ophthalmology Country of Publication: United States NLM ID: 101595919 Publication Model: Print Cited Medium: Internet ISSN: 2164-2591 (Electronic) Linking ISSN: 21642591 NLM ISO Abbreviation: Transl Vis Sci Technol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Rockville, Md. : Association for Research in Vision and Ophthalmology
    • Subject Terms:
      Quality of Life*; China ; Humans ; Psychometrics ; Reproducibility of Results ; Surveys and Questionnaires
    • Abstract:
      Purpose: The purpose of this study was to assess whether a Chinese translated version of the 33-item Indian Vision Function Questionnaire (IND-VFQ-33) forms a valid measurement scale and to evaluate its psychometric properties based on the method of successive dichotomizations (MSD).
      Methods: The English version of the IND-VFQ-33 was translated, back translated, and cross-culturally adapted for use in China. It was interviewer administered to patients with cataracts. MSD, a polytomous Rasch model that estimates ordered thresholds, was used to assess and optimize psychometric properties of the overall scale and three subscales separately.
      Results: One hundred and seventy-nine patients provided complete responses. After the removal of 2 misfitting items, a revised 31-item overall scale demonstrated adequate precision (person reliability [PR] = 0.92) and no misfitting items. The general functioning subscale fit the MSD model well after removing two misfitting items. The psychosocial impact subscale and the visual symptoms subscale were not considered further due to poor measurement precision. After addressing psychometric deficiencies, a 31-item overall scale (IND-VFQ-31-CN) and a 19-item general functioning subscale (IND-VFQ-GF-19-CN) were developed.
      Conclusions: The original IND-VFQ-33 required re-engineering to form valid measures for use in China. The revised overall scale and general functioning subscale demonstrated adequate MSD based psychometric properties.
      Translational Relevance: The revised IND-VFQ-33 is a valid patient-reported outcome assessment for Chinese patients with cataract based on MSD analysis.
    • References:
      J Cataract Refract Surg. 2010 Jul;36(7):1181-8. (PMID: 20610098)
      PLoS One. 2016 Oct 13;11(10):e0164182. (PMID: 27736889)
      Med Care. 2004 Jan;42(1 Suppl):I17-24. (PMID: 14707752)
      Acta Orthop Belg. 2016 Aug;82(2):189-196. (PMID: 27682279)
      Optom Vis Sci. 2009 Jul;86(7):E836-44. (PMID: 19521266)
      Curr Opin Ophthalmol. 2017 Jan;28(1):98-103. (PMID: 27820750)
      PLoS One. 2012;7(8):e44268. (PMID: 22952945)
      Br J Ophthalmol. 2005 May;89(5):621-7. (PMID: 15834097)
      Br J Ophthalmol. 2012 May;96(5):619-23. (PMID: 22308172)
      Indian J Ophthalmol. 2008 Jul-Aug;56(4):307-12. (PMID: 18579990)
      Diabetes Care. 2016 Sep;39(9):1643-9. (PMID: 27555623)
      J Cataract Refract Surg. 2014 May;40(5):774-84. (PMID: 24767911)
      Optom Vis Sci. 2013 Aug;90(8):720-44. (PMID: 23873034)
      Acta Ophthalmol. 2010 Nov;88(7):797-803. (PMID: 19563369)
      Cornea. 2020 Mar;39(3):386-393. (PMID: 31599780)
      Br J Ophthalmol. 2016 May;100(5):588-93. (PMID: 26917676)
      Ophthalmol Glaucoma. 2019 Sep-Oct;2(5):357-363. (PMID: 31552395)
      Invest Ophthalmol Vis Sci. 2011 Sep 01;52(9):6971-7. (PMID: 21810983)
      PLoS One. 2018 Oct 18;13(10):e0206106. (PMID: 30335832)
      J Cataract Refract Surg. 2010 May;36(5):718-32. (PMID: 20457362)
      Am J Ophthalmol. 2017 Jul;179:10-17. (PMID: 28414043)
      Ophthalmology. 2010 Oct;117(10):1900-7, 1907.e1. (PMID: 20570364)
      Zhonghua Yi Xue Za Zhi. 2012 Aug 7;92(29):2055-8. (PMID: 23253808)
      Indian J Ophthalmol. 2015 Jun;63(6):511-5. (PMID: 26265642)
      Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):137-42. (PMID: 18766368)
      Optom Vis Sci. 2009 Oct;86(10):1160-8. (PMID: 19741562)
      Sci Rep. 2019 Oct 25;9(1):15326. (PMID: 31653904)
      Invest Ophthalmol Vis Sci. 2010 Feb;51(2):694-700. (PMID: 19684011)
      Invest Ophthalmol Vis Sci. 2011 Aug 01;52(9):6081-8. (PMID: 21693607)
      Invest Ophthalmol Vis Sci. 2014 Jun 10;55(7):4413-20. (PMID: 24917139)
      Med Sci Monit. 2018 Jan 16;24:317-323. (PMID: 29335399)
      Patient Relat Outcome Meas. 2019 Jan 24;10:9-24. (PMID: 30774489)
      Br J Ophthalmol. 2010 Jun;94(6):777-81. (PMID: 19965824)
      J Cataract Refract Surg. 2019 Nov;45(11):1575-1583. (PMID: 31585852)
      PLoS One. 2019 Apr 10;14(4):e0215128. (PMID: 30970024)
    • Publication Date:
      Date Created: 20210608 Date Completed: 20210628 Latest Revision: 20210628
    • Publication Date:
      20221213
    • Accession Number:
      PMC8196417
    • Accession Number:
      10.1167/tvst.10.7.8
    • Accession Number:
      34100924